Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 2400Neoplasms 1817Carcinoma, Non-Small-Cell Lung 1598Prostatic Neoplasms 1306Colorectal Neoplasms 1139Lung Neoplasms 985Neoplasm Metastasis 836Multiple Myeloma 794Leukemia, Myeloid, Acute 767Ovarian Neoplasms 677Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 584Carcinoma, Hepatocellular 571Recurrence 564Brain Neoplasms 528Glioblastoma 515Head and Neck Neoplasms 503Stomach Neoplasms 498Triple Negative Breast Neoplasms 465Lymphoma 456Uterine Cervical Neoplasms 453Carcinoma, Renal Cell 424Precursor Cell Lymphoblastic Leukemia-Lymphoma 408Lymphoma, Non-Hodgkin 390Endometrial Neoplasms 384Sarcoma 371Lymphoma, Follicular 358Urinary Bladder Neoplasms 355Hematologic Neoplasms 355

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gaucher Disease × 1 year × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡